37 research outputs found
A New Perspective on Huntington's Disease: How a Neurological Disorder Influences the Peripheral Tissues
Huntington’s disease (HD) is a neurodegenerative disorder caused by a toxic, aggregationprone
expansion of CAG repeats in the HTT gene with an age-dependent progression that leads to
behavioral, cognitive and motor symptoms. Principally affecting the frontal cortex and the striatum,
mHTT disrupts many cellular functions. In fact, increasing evidence shows that peripheral tissues
are affected by neurodegenerative diseases. It establishes an active crosstalk between peripheral
tissues and the brain in different neurodegenerative diseases. This review focuses on the current
knowledge of peripheral tissue effects in HD animal and cell experimental models and identifies
biomarkers and mechanisms involved or affected in the progression of the disease as new therapeutic
or early diagnostic options. The particular changes in serum/plasma, blood cells such as lymphocytes,
immune blood cells, the pancreas, the heart, the retina, the liver, the kidney and pericytes as a part
of the blood–brain barrier are described. It is important to note that several changes in different
mouse models of HD present differences between them and between the different ages analyzed. The
understanding of the impact of peripheral organ inflammation in HD may open new avenues for the
development of novel therapeutic targets
Anti-Inflammatory (M2) Response Is Induced by a sp(2)-Iminosugar Glycolipid Sulfoxide in Diabetic Retinopathy
Diabetic retinopathy (DR) is one of the most common complications of Diabetes Mellitus (DM) and is directly associated with inflammatory processes. Currently, neuro-inflammation is considered an early event in DR and proceeds via microglia polarization. A hallmark of DR is the presence of retinal reactive gliosis. Here we report the beneficial effect of (S (S),1R)-1-docecylsulfiny-5N,6O-oxomethylidenenojirimycin ((Ss)-DS-ONJ), a member of the sp(2)-iminosugar glycolipid (sp(2)-IGL) family, by decreasing iNOS and inflammasome activation in Bv.2 microglial cells exposed to pro-inflammatory stimuli. Moreover, pretreatment with (Ss)-DS-ONJ increased Heme-oxygenase (HO)-1 as well as interleukin 10 (IL10) expression in LPS-stimulated microglial cells, thereby promoting M2 (anti-inflammatory) response by the induction of Arginase-1. The results strongly suggest that this is the likely molecular mechanism involved in the anti-inflammatory effects of (S (S))-DS-ONJ in microglia. (S (S))-DS-ONJ further reduced gliosis in retinal explants from type 1 diabetic BB rats, which is consistent with the enhanced M2 response. In conclusion, targeting microglia polarization dynamics in M2 status by compounds with anti-inflammatory activities offers promising therapeutic interventions at early stages of DR
Assay for high glucose-mediated islet cell sensitization to apoptosis induced by streptozotocin and cytokines
Pancreatic β-cell apoptosis is known to participate in the β-cell destruction process that occurs in diabetes. It has been described that high glucose level induces a hyperfunctional status which could provoke apoptosis. This phenomenon is known as glucotoxicity and has been proposed that it can play a role in type 1 diabetes mellitus pathogenesis. In this study we develop an experimental design to sensitize pancreatic islet cells by high glucose to streptozotocin (STZ) and proinflammatory cytokines [interleukin (IL)-1β, tumor necrosis factor (TNF)-α and interferon (IFN)-γ]-induced apoptosis. This method is appropriate for subsequent quantification of apoptotic islet cells stained with Tdt-mediated dUTP Nick-End Labeling (TUNEL) and protein expression assays by Western Blotting (WB)
IGF-1, inflammation and retinal degeneration: A close network
Retinal degenerative diseases are a group of heterogeneous diseases that include age-related macular degeneration (AMD), retinitis pigmentosa (RP), and diabetic retinopathy (DR). The progressive degeneration of the retinal neurons results in a severe deterioration of the visual function. Neuroinflammation is an early hallmark of many neurodegenerative disorders of the retina including AMD, RP and DR. Microglial cells, key components of the retinal immune defense system, are activated in retinal degenerative diseases. In the microglia the interplay between the proinflammatory/classically activated or antiinflammatory/alternatively activated phenotypes is a complex dynamic process that occurs during the course of disease due to the different environmental signals related to pathophysiological conditions. In this regard, an adequate transition from the proinflammatory to the anti-inflammatory response is necessary to counteract retinal neurodegeneration and its subsequent damage that leads to the loss of visual function. Insulin like-growth factor-1 (IGF-1) has been considered as a pleiotropic factor in the retina under health or disease conditions and several effects of IGF-1 in retinal immune modulation have been described. In this review, we provide recent insights of inflammation as a common feature of retinal diseases (AMD, RP and RD) highlighting the role of microglia, exosomes and IGF-1 in this process.The work of AIA and ÁMV has been funded by grants from European Union (project H2020-MSCA-ITN TREATMENT Grant Agreement number: 721236 and project EUROCONDOR FP7 Grant Agreement number 278040), grant from the Spanish Ministry of Economy and Competitiveness: SAF2015-65267-R (MINECO/FEDER) and
grants from the Spanish ISCIII (CIBERdem) and INFLAMES (ISCIII PIE14/00045, co-funded by ERDF, Investing in your future).Peer Reviewe
Recommended from our members
Anti-proliferative effect of pro-inflammatory cytokines in cultured β cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide -1
Pancreatic β-cell homeostasis is a balance between programmed cell death (apoptosis) and regeneration. Although autoimmune diabetes mellitus type 1 (DM1) is the most-studied cause of β-cell mass loss by pro-inflammatory cytokine-induced apoptosis, influences of a pro-inflammatory environment on β-cell regenerative response have been poorly studied. In this study, we assess the anti-proliferative effect of pro-inflammatory cytokines and glucose concentration on rat pancreatic β cells and the potential protective role of glucagon-like peptide (GLP-1). Apoptotic and proliferating islet cells were stained using the DeadEnd Fluorimetric TUNEL System and 5-bromo-2′-deoxyuridine label respectively, in the presence–absence of varying concentrations of glucose, pro-inflammatory cytokines, and GLP-1. The potential signaling pathways involved were evaluated by western blot. Considerable anti-proliferative effects of pro-inflammatory cytokines interleukin (IL)-1β, interferon (IFN)-γ, and tumour necrosis factor-α (TNF-α) were observed. The effects were synergistic and independent of glucose concentration, and appeared to be mediated by the inhibition of extracellular signal-regulated kinase 1/2 (ERK1/2) activation, the signaling pathway involved in β-cell replication. GLP-1 completely reversed the cytokine-induced inhibition of ERK phosphorylation and increased β-cell proliferation threefold in cytokine-treated cultures. While pro-inflammatory cytokines reduced islet cell ERK1/2 activation and β-cell proliferation in pancreatic islet culture, GLP-1 was capable of reversing this effect. These data suggest a possible pharmacological application of GLP-1 in the treatment of early stage DM1, to prevent the loss of pancreatic β cells as well as to delay the development of overt diabetes
Diapiric Structures in the Tinto River Estuary (SW Spain) Caused by Artificial Load of an Industrial Stockpile
The mouth of the Tinto River is located on the southwest coast of the Iberian Peninsula in the northwest of the Gulf of Cadiz. The river flows into an estuarine system shared with the Odiel River, commonly known as the “Ría de Huelva”. In the 1960s, a wide area of ancient salt marshes was transformed by a stockpile of industrial wastes of phosphogypsum, reaching a height of 35 m above the level of the salt marsh at its highest point. Two surveys using high-resolution seismic reflection in conjunction with a parametric profiler were carried out in 2016 and 2018. The purpose of these geophysical studies was the realization of a 3D model of the sedimentary units constituting the most recent filling of the estuary. The records present abundant extrusion structures located on the margins of the waste stockpiles, which break the visible stratification of the surficial units of the estuary. In some sectors, these structures have reached the estuarine surface and have, therefore, a morphological expression on the estuarine floor. The origin of these structures is interpreted as a vertical escape of fluidized sediments from lower units caused by overpressure from stacking
Characterization of NO-Induced Nitrosative Status in Human Placenta from Pregnant Women with Gestational Diabetes Mellitus
Dysregulation of NO production is implicated in pregnancy-related diseases, including gestational diabetes mellitus (GDM). The role of NO and its placental targets in GDM pregnancies has yet to be determined. S-Nitrosylation is the NO-derived posttranslational protein modification that can modulate biological functions by forming NO-derived complexes with longer half-life, termed S-nitrosothiol (SNO). Our aim was to examine the presence of endogenous S-nitrosylated proteins in cysteine residues in relation to antioxidant defense, apoptosis, and cellular signal transduction in placental tissue from control (n = 8) and GDM (n = 8) pregnancies. S-Nitrosylation was measured using the biotin-switch assay, while the expression and protein activity were assessed by immunoblotting and colorimetric methods, respectively. Results indicated that catalase and peroxiredoxin nitrosylation levels were greater in GDM placentas, and that was accompanied by reduced catalase activity. S-Nitrosylation of ERK1/2 and AKT was increased in GDM placentas, and their activities were inhibited. Activities of caspase-3 and caspase-9 were increased, with the latter also showing diminished nitrosylation levels. These findings suggest that S-nitrosylation is a little-known, but critical, mechanism by which NO directly modulates key placental proteins in women with GDM and, as a consequence, maternal and fetal anomalies during pregnancy can occur.España Ministerio de Educación y Ciencia BMC2003-07072-C03-01Junta de Andalucía CVI27
A surgical model of short bowel syndrome induces a long-lasting increase in pancreatic beta-cell mass
Several surgical techniques are used
nowadays as a severe treatment for obesity and diabetes
mellitus type 2. These techniques are aggressive due to
drastic changes in the nutrient flow and non-reversible
modifications on the digestive tube. In this paper we
present the effects of a massive intestinal resection on
the pancreas. Results have shown that short bowel
technique is less aggressive to normal anatomy and
physiology of the intestinal tract than Gastric bypass or
biliopancreatic diversion (e.g.). In this paper we
reproduce a model of short bowel syndrome (SIC), with
similar surgical conditions and clinical complications as
seen in human cases. This work was conducted on
normal Wistar rats, with no other concurrent factors, in
order to determine the effects on normal pancreas islets.
We measured pancreatic implications by histomorphometric studies, which included beta-cell mass by
immunocytochemistry, and apoptosis/proliferation test
with TUNEL technique and Ki-67. Briefly, we reported
on an increased relative area of the islets of the pancreas,
as well as an increase in the average size of islets in the
SIC versus the control group. Furthermore we stated that
this increase in size of the pancreatic islets is due to the
mechanisms of proliferation of beta cells in animals
undergoing SIC. These goals could reveal a direct
influence of surgical modification of the digestive tract
over the pancreatic beta cell homeostasis. In this sense,
there are many potential stimulators of intestinal
adaptation, including peptide hormones and growth
components which are associated or involved as
effectors of the endocrine pancreas
Ghrelin mitigates beta-cell mass loss during insulitis in an animal model of autoimmune diabetes mellitus, the BioBreeding/Worcester rat
Background Ghrelin is a peptide hormone with pleiotropic effects. It stimulates cell proliferation and inhibits apoptosis-mediated cell death. It prevents diabetes mellitus in several models of chemical, surgical and biological toxic insults to pancreas in both in vivo and in vitro models and promotes glucose-stimulated insulin secretion under cytotoxic conditions. It has not yet been tested in vivo in an autoimmune model of diabetes with a persistent insult to the beta-cell. Given the immunomodulating effects of ghrelin and its trophic effects on beta-cells, we hypothesized that ghrelin treatment during the early stages of insulitis would delay diabetes onset.Methods BioBreeding/Worcester male rats received ghrelin (10 ng/kg/day) before insulitis development. Glucose metabolism was characterized by glucose and insulin tolerance tests. beta-cell mass, islet area, islet number, beta-cell clusters, proliferation and apoptosis and degree of insulitis were analysed by histomorphometry. A Kaplan-Meier survival curve was plotted and analysed applying the log-rank (Mantel-Cox) test.Results Ghrelin treatment significantly reduced the probability of developing diabetes in our model (